Logo image of OPTN

OPTINOSE INC (OPTN) Stock Fundamental Analysis

NASDAQ:OPTN - Nasdaq - US68404V1008 - Common Stock - Currency: USD

5.64  -0.06 (-1.05%)

Fundamental Rating

2

Overall OPTN gets a fundamental rating of 2 out of 10. We evaluated OPTN against 195 industry peers in the Pharmaceuticals industry. OPTN may be in some trouble as it scores bad on both profitability and health. OPTN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year OPTN has reported negative net income.
OPTN had a negative operating cash flow in the past year.
OPTN had negative earnings in each of the past 5 years.
In the past 5 years OPTN always reported negative operating cash flow.
OPTN Yearly Net Income VS EBIT VS OCF VS FCFOPTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -34.51%, OPTN perfoms like the industry average, outperforming 50.54% of the companies in the same industry.
Industry RankSector Rank
ROA -34.51%
ROE N/A
ROIC N/A
ROA(3y)-44.79%
ROA(5y)-50.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OPTN Yearly ROA, ROE, ROICOPTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 -1K

1.3 Margins

The Gross Margin of OPTN (90.46%) is better than 93.55% of its industry peers.
In the last couple of years the Gross Margin of OPTN has grown nicely.
The Profit Margin and Operating Margin are not available for OPTN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 90.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y2.53%
OPTN Yearly Profit, Operating, Gross MarginsOPTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10K -20K -30K -40K

More info and screens

1

2. Health

2.1 Basic Checks

OPTN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OPTN has less shares outstanding
Compared to 5 years ago, OPTN has less shares outstanding
Compared to 1 year ago, OPTN has a worse debt to assets ratio.
OPTN Yearly Shares OutstandingOPTN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
OPTN Yearly Total Debt VS Total AssetsOPTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -5.24, we must say that OPTN is in the distress zone and has some risk of bankruptcy.
OPTN has a worse Altman-Z score (-5.24) than 63.98% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.24
ROIC/WACCN/A
WACC10.23%
OPTN Yearly LT Debt VS Equity VS FCFOPTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.79 indicates that OPTN may have some problems paying its short term obligations.
OPTN's Current ratio of 0.79 is on the low side compared to the rest of the industry. OPTN is outperformed by 90.86% of its industry peers.
OPTN has a Quick Ratio of 0.79. This is a bad value and indicates that OPTN is not financially healthy enough and could expect problems in meeting its short term obligations.
OPTN's Quick ratio of 0.72 is on the low side compared to the rest of the industry. OPTN is outperformed by 90.32% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.72
OPTN Yearly Current Assets VS Current LiabilitesOPTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

6

3. Growth

3.1 Past

OPTN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -560.00%.
Looking at the last year, OPTN shows a very strong growth in Revenue. The Revenue has grown by 25.80%.
Measured over the past years, OPTN shows a very strong growth in Revenue. The Revenue has been growing by 58.62% on average per year.
EPS 1Y (TTM)-560%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)25.8%
Revenue growth 3Y13.06%
Revenue growth 5Y58.62%
Sales Q2Q%3.1%

3.2 Future

Based on estimates for the next years, OPTN will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.13% on average per year.
OPTN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.13% yearly.
EPS Next Y-872.19%
EPS Next 2Y-174.85%
EPS Next 3Y-56.82%
EPS Next 5Y14.13%
Revenue Next Year12.22%
Revenue Next 2Y24.69%
Revenue Next 3Y23.05%
Revenue Next 5Y23.13%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
OPTN Yearly Revenue VS EstimatesOPTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
OPTN Yearly EPS VS EstimatesOPTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -10 -20 -30 -40

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OPTN. In the last year negative earnings were reported.
Also next year OPTN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPTN Price Earnings VS Forward Price EarningsOPTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPTN Per share dataOPTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

OPTN's earnings are expected to decrease with -56.82% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-174.85%
EPS Next 3Y-56.82%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OPTN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OPTINOSE INC

NASDAQ:OPTN (2/11/2025, 12:46:56 PM)

5.64

-0.06 (-1.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners76.94%
Inst Owner Change-39%
Ins Owners5.9%
Ins Owner Change1.78%
Market Cap850.68M
Analysts84
Price Target24.23 (329.61%)
Short Float %N/A
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)68.27%
Min EPS beat(2)36.54%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)33.39%
Min EPS beat(4)-9.44%
Max EPS beat(4)100%
EPS beat(8)6
Avg EPS beat(8)31.69%
EPS beat(12)9
Avg EPS beat(12)22.07%
EPS beat(16)12
Avg EPS beat(16)17.79%
Revenue beat(2)0
Avg Revenue beat(2)-7.65%
Min Revenue beat(2)-12.9%
Max Revenue beat(2)-2.4%
Revenue beat(4)2
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-12.9%
Max Revenue beat(4)8.75%
Revenue beat(8)5
Avg Revenue beat(8)3.03%
Revenue beat(12)6
Avg Revenue beat(12)-0.49%
Revenue beat(16)8
Avg Revenue beat(16)-1.06%
PT rev (1m)691.67%
PT rev (3m)578.57%
EPS NQ rev (1m)-1415.79%
EPS NQ rev (3m)-4700%
EPS NY rev (1m)-1369.88%
EPS NY rev (3m)-1240.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-30.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.39
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.64
EYN/A
EPS(NY)-2.42
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0.6
BVpS-0.27
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.51%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 90.46%
FCFM N/A
ROA(3y)-44.79%
ROA(5y)-50.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y2.53%
F-Score5
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 41.18%
Cap/Sales 0.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.72
Altman-Z -5.24
F-Score5
WACC10.23%
ROIC/WACCN/A
Cap/Depr(3y)39.69%
Cap/Depr(5y)41.44%
Cap/Sales(3y)0.26%
Cap/Sales(5y)0.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-560%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y-872.19%
EPS Next 2Y-174.85%
EPS Next 3Y-56.82%
EPS Next 5Y14.13%
Revenue 1Y (TTM)25.8%
Revenue growth 3Y13.06%
Revenue growth 5Y58.62%
Sales Q2Q%3.1%
Revenue Next Year12.22%
Revenue Next 2Y24.69%
Revenue Next 3Y23.05%
Revenue Next 5Y23.13%
EBIT growth 1Y4.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year53.84%
EBIT Next 3Y38.42%
EBIT Next 5YN/A
FCF growth 1Y40.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.55%
OCF growth 3YN/A
OCF growth 5YN/A